Bottom line
CHNA vs FSPHX: the short answer
CHNA (Loncar China BioPharma ETF) and FSPHX (Health Care Portfolio) are both etfs.
Updated Nov 19, 2026
CHNA vs FSPHX side by side
| CHNA | FSPHX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Grayscale | Fidelity |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | — | 0.62% |
| Annual cost per $10k | — | $62 |
| 10-yr cost on $10k (prospectus) | — | $774 |
| Max front load | None | — |
| 12b-1 fee | — | 0% |
| 1-yr return | — | +14.4% |
| 5-yr return (annualized) | — | +4.0% |
| 10-yr return (annualized) | — | +9.0% |
| Best quarter | — | +22.2% |
| Worst quarter | — | −15.0% |
| Net assets (fund) | — | $5.8B |
| Number of holdings | — | 152 |
| Portfolio turnover | — | 69% |
| Returns as of | — | Apr 30, 2026 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
CHNA and FSPHX share none of their top holdings.
CHNA top 10
FSPHX top 10
- ELI LILLY and CO — 8.03%
- Danaher Corp — 6.89%
- JOHNSON and JOHNSON — 4.91%
- Thermo Fisher Scientific Inc — 4.33%
- Unitedhealth Group Inc — 3.49%
- Alnylam Pharmaceuticals Inc — 2.40%
- Gilead Sciences Inc — 2.21%
- Boston Scientific Corp — 2.17%
- Ascendis Pharma A/s — 2.17%
- Fidelity Revere Street Trust — 2.17%
FAQ
What is the difference between CHNA and FSPHX?
CHNA (Loncar China BioPharma ETF) and FSPHX (Health Care Portfolio) are both etfs.
Should I own both CHNA and FSPHX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.